Genetics of serum BDNF: Meta-analysis of the Val66Met and genome-wide association study

World Journal of Biological Psychiatry

Volumn 14, Issue 8, 2013, Pages 583-589

  Terracciano, Antonio ^a   Piras, Maria Grazia ^b   Lobina, Monia ^b   Mulas, Antonella ^b   Meirelles, Osorio ^a   Sutin, Angelina R ^a   Chan, Wayne ^a   Sanna, Serena ^b   Uda, Manuela ^b   Crisponi, Laura ^b   Schlessinger, David ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b Milan Unit   (Italy)

Author keywords

Brain derived neurotrophic factor (BDNF); GWAS; NTRK3; Serum; Val66Met

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; TYROSINE KINASE RECEPTOR;

ARTICLE; BLOOD ANALYSIS; COMMUNITY SAMPLE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; ITALY; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

BRAIN-DERIVED NEUROTROPHIC FACTOR; GENOME-WIDE ASSOCIATION STUDY; HUMANS; ITALY;

EID: 84887880783     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2011.616533     Document Type: Article

References (51)

1. Alzheimer Research Forum. 2011. http://www.alzforum.org/res/com/gen/ alzgene/meta.asp?geneID=109&polyID=334.
2. Athanasiu L, Mattingsdal M, Melle I., Inderhaug E, Lien T, Agartz I., et al. 2011. Intron 12 in NTRK3 is associated with bipolar disorder. Psychiatry Res 185: 358-362.
3. Bhang S, Ahn JH, Choi SW. 2011. Brain-derived neurotrophic factor and serotonin transporter gene-linked promoter region genes alter serum levels of brain-derived neurotrophic factor in humans. J Affect Disord 128: 299-304.
4. Bocchio-Chiavetto L., Bagnardi V, Zanardini R., Molteni R, Nielsen GM, Placentino A, et al. 2010. Serum and plasma BDNF levels in major depression: A replication study and meta-analyses. World J Biol Psychiatry 11: 763-773.
5. Brandys MK, Kas MJ, van Elburg AA, Campbell IC, Adan RA. 2011. A meta-analysis of circulating BDNF concentrations in anorexia nervosa. World J Biol Psychiatry 12: 444-454.
6. Bremer T, Diamond C, McKinney R., Shehktman T, Barrett TB, Herold C. et al. 2007. The pharmacogenetics of lithium response depends upon clinical co-morbidity. Mol Diagn Ther 11: 161-170. (Pubitemid 46983408)
7. Brunoni AR, Lopes M, Fregni F. 2008. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacology 11: 1169-1180.
8. Bus BA, Tendolkar I, Franke B., de Graaf J, Heijer MD, Buitelaar J.K., et al. 2012. Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people. World J Biol Psychiatry 13: 39-47.
9. Cattaneo A, Bocchio-Chiavetto L, Zanardini R., Marchina E, Bellotti D, Milanesi E., et al. 2010. BDNF Val66Met polymorphism and protein levels in amniotic fluid. BMC Neurosci 11: 16.
10. Cavalli-Sforza L.L., Menozzi P, Piazza A. 1994. The history and geography of human genes. Princeton, NJ: Princeton University Press.
11. Chen WM, Abecasis GR. 2007. Family-based association tests for genomewide association scans. Am J Hum Genet 81: 913-926. (Pubitemid 47580246)
12. de Moor M.H., Costa PT, Terracciano A, Krueger R.F., de Geus EJ, Toshiko T, et al. 2012. Meta-analysis of genome-wide association studies for personality. Mol Psychiatry 17: 337-349.
13. Diniz BS, Teixeira AL, Talib L.L., Mendonca VA, Gattaz WF, Forlenza OV. 2010. Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression. World J Biol Psychiatry 11: 550-555.
14. Duman RS, Monteggia LM. 2006. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59: 1116-1127.
15. Duncan LE, Hutchison KE, Carey G, Craighead WE. 2009. Variation in brain-derived neurotrophic factor (BDNF) gene is associated with symptoms of depression. J Affect Disord 115: 215-219.
16. Egan MF, Kojima M, Callicott J.H., Goldberg TE, Kolachana BS, Bertolino A, et al. 2003. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112: 257-269. (Pubitemid 36144114)
17. Elzinga, BM, Molendijk ML, Oude Voshaar RC, Bus BA, Prickaerts J, Spinhoven P, et al. 2011. The impact of childhood abuse and recent stress on serum brain-derived neurotrophic factor and the moderating role of BDNF Val66Met. Psychopharmacology (Berlin) 214: 319-328.
18. Feng Y, Vetro A, Kiss E., Kapornai K, Daroczi G, Mayer L., et al. 2008. Association of the neurotrophic tyrosine kinase receptor 3 (NTRK3) gene and childhood-onset mood disorders. Am J Psychiatry 165: 610-616. (Pubitemid 351705338)
19. Forlenza OV, Diniz BS, Teixeira A.L., Ojopi EB, Talib LL, Mendonca VA, et al. 2010. Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World J Biol Psychiatry 11: 774-780.
20. Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160: 636-645. (Pubitemid 41079594)
21. Jiang H, Wang R, Liu Y., Zhang Y, Chen ZY. 2009. BDNF Val66-Met polymorphism is associated with unstable angina. Clin Chim Acta 400: 3-7.
22. Lamballe F, Klein R, Barbacid, M. 1991. trkC, a new member of the trk family of tyrosine protein kinases, is a receptor for neurotrophin-3. Cell 66: 967-979. (Pubitemid 121001730)
23. Lang UE, Hellweg R, Gallinat J. 2004. BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 29: 795-798. (Pubitemid 38402487)
24. Lang UE, Hellweg R, Sander T., Gallinat J. 2009. The Met allele of the BDNF Val66Met polymorphism is associated with increased BDNF serum concentrations [letter]. Mol Psychiatry 14: 120-122.
25. Mattson MP, Maudsley S, Martin B. 2004. BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurode-generative disorders. Trends Neurosci 27: 589-594. (Pubitemid 39221394)
26. Minelli A, Zanardini R, Bonvicini C., Sartori R, Pedrini L, Gennarelli M., et al. 2011. BDNF serum levels, but not BDNF Val66Met genotype, are correlated with personality traits in healthy subjects. Eur Arch Psychiatry Clin Neurosci 261: 323-329.
27. Molendijk ML, Bus BA, Spinhoven P, Penninx B.W., Kenis G., Prickaerts J, et al. 2011. Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 16: 1088-1095.
28. Mossner R, Mikova O, Koutsilieri E., Saoud M, Ehlis AC, Muller N, et al. 2007. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry 8: 141-174. (Pubitemid 47163382)
29. Muinos-Gimeno M., Guidi M, Kagerbauer B., Martin-Santos R, Navines R, Alonso P., et al. 2009. Allele variants in functional MicroRNA target sites of the neurotrophin-3 receptor gene (NTRK3) as susceptibility factors for anxiety disorders. Hum Mutat 30: 1062-1071.
30. Ozan E, Okur H, Eker C., Eker OD, Gonul AS, Akarsu N. 2010. The effect of depression, BDNF gene val66met polymorphism and gender on serum BDNF levels. Brain Res Bull 81: 61-65.
31. Pilia G, Chen WM, Scuteri A, Orrú M, Albai G, Dei M, et al. 2006. Heritability of cardiovascular and personality traits in 6,148 Sardinians. PloS Genetics 2: e132.
32. Roth TL, Lubin FD, Funk A.J., Sweatt JD. 2009. Lasting epigenetic influence of early-life adversity on the BDNF gene. Biol Psychiatry 65: 760-769.
33. Sanchez-Mora C., Ribases M, Ramos-Quiroga JA, Casas M., Bosch R, Boreatti-Hummer A, et al. 2010. Meta-analysis of brain-derived neurotrophic factor p. Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet 153B: 512-523.
34. Sanna S, Jackson AU, Nagaraja R, Willer C.J., Chen WM, Bonnycastle LL, et al. 2008. Common variants in the GDF5-UQCC region are associated with variation in human height. Nat Genet 40: 198-203. (Pubitemid 351171401)
35. Schizophrenia Research Forum. 2011. http://www.szgene.org/meta.asp? geneID=2&polyID=28.
36. Schmidt HD, Duman RS. 2010. Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35: 2378-2391.
37. Schumacher J, Jamra RA, Becker T, Ohlraun S., Klopp N, Binder EB, et al. 2005. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol Psychiatry 58: 307-314. (Pubitemid 41133624)
38. Sutin AR, Scuteri A, Lakatta E.G., Tarasov KV, Ferrucci L, Costa PT Jr, et al. 2010. Trait antagonism and the progression of arterial thickening: women with antagonistic traits have similar carotid arterial thickness as men. Hypertension 56: 617-622.
39. Swardfager W, Herrmann N, Marzolini S., Saleem M, Shammi P, Oh P.I., et al. 2011. Brain derived neurotrophic factor, cardiopulmonary fitness and cognition in patients with coronary artery disease. Brain Behav Immun 25: 1264-1271.
40. Terracciano A, Martin B, Ansari D., Tanaka T, Ferrucci L, Maudsley S., et al. 2010a. Plasma BDNF concentration, Val66-Met genetic variant and depression-related personality traits. Genes Brain Behav 9: 512-518.
41. Terracciano A, Sanna S, Uda M., Deiana B, Usala G, Busonero F., et al. 2010b. Genome-wide association scan for five major dimensions of personality. Mol Psychiatry 15: 647-656.
42. Terracciano A, Tanaka T, Sutin A.R., Deiana B., Balaci L, Sanna S, et al. 2010c. BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism. Neuropsychopharmacology 35: 1083-1089.
43. Terracciano A, Tanaka T, Sutin A.R., Sanna S., Deiana B, Lai S, et al. 2010d. Genome-wide association scan of trait depression. Biol Psychiatry 68: 811-817.
44. Terracciano A, Lobina M, Piras M.G., Mulas A., Cannas A, Meirelles O, et al. 2011. Lower serum BDNF associated with higher neuroticism and depressive symptoms. Psychosom Med 73: 638-642.
45. Trajkovska V, Marcussen AB, Vinberg M, Hartvig P., Aznar S, Knudsen GM. 2007. Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull 73: 143-149. (Pubitemid 46722657)
46. Verma R, Holmans P, Knowles J.A., Grover D., Evgrafov OV, Crowe RR, et al. 2008. Linkage disequilibrium mapping of a chromosome 15q25-26 major depression linkage region and sequencing of NTRK3. Biol Psychiatry 63: 1185-1189.
47. Vinberg M, Trajkovska V, Bennike B., Knorr U, Knudsen GM, Kessing LV. 2009. The BDNF Val66Met polymorphism: relation to familiar risk of affective disorder, BDNF levels and salivary cortisol. Psychoneuroendocrinology 34: 1380-1389.
48. Xiu MH, Hui L, Dang Y.F., Hou TD, Zhang CX, Zheng YL, et al. 2009. Decreased serum BDNF levels in chronic institutionalized schizophrenia on long-term treatment with typical and atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 33: 1508-1512.
49. Yoshimura R, Kishi T, Suzuki A., Umene-Nakano W, Ikenouchi-Sugita A, Hori H., et al. 2011. The brain-derived neurotrophic factor (BDNF) polymorphism Val66Met is associated with neither serum BDNF level nor response to selective serotonin reuptake inhibitors in depressed Japanese patients. Prog Neuropsychopharmacol Biol Psychiatry 35: 1022-1025.
50. Yu H, Zhang Z, Shi Y., Bai F, Xie C, Qian Y., et al. 2008. Association study of the decreased serum BDNF concentrations in amnestic mild cognitive impairment and the Val66Met polymorphism in Chinese Han. J Clin Psychiatry 69: 1104-1111. (Pubitemid 352031594)
51. Zhang XY, Zhou DF, Wu G.Y., Cao LY, Tan YL, Haile CN, et al. 2008. BDNF levels and genotype are associated with antipsychotic-induced weight gain in patients with chronic schizophrenia. Neuropsychopharmacology 33: 2200-2205. (Pubitemid 351992089)